Showing 801 - 820 results of 4,041 for search '"kidney"', query time: 0.15s Refine Results
  1. 801

    Serum hydroxycotinine was associated with chronic kidney disease (CKD): a cross-sectional study based on NHANES by Meng’en Zhu, Zhimin Bi, Yaoling Wang, Wei Li

    Published 2024-12-01
    “…Objective Smoking has been suggested as a modifiable and cardiovascular risk factor for chronic kidney disease (CKD). Although long-term smoking has been associated with CKD, the potential relationship between its metabolite hydroxycotinine and CKD has not been clarified.Methods A total of 8,544 participants aged 20 years and above from the National Health and Nutrition Examination Survey (NHANES) 2017 - March 2020 were enrolled in our study. …”
    Get full text
    Article
  2. 802
  3. 803
  4. 804

    Recompensation of Heart and Kidney Function after Treatment with Peritoneal Dialysis in a Case of Congestive Heart Failure by Lars P. Kihm, Vinzent Hankel, Christian Zugck, Andrew Remppis, Vedat Schwenger

    Published 2011-01-01
    “…Furthermore, residual kidney function increased during the long-term followup, and subsequently peritoneal dialysis was ceased. …”
    Get full text
    Article
  5. 805

    Anthropometric and Biochemical Profile of Children and Adolescents with Chronic Kidney Disease in a Predialysis Pediatric Interdisciplinary Program by Vanessa R. Silva, Cristina B. Soares, Juliana O. Magalhães, Isabella Peixoto de Barcelos, Debora C. Cerqueira, Ana Cristina Simões e Silva, Eduardo A. Oliveira

    Published 2015-01-01
    “…This is longitudinal retrospective observational cohort study that evaluated anthropometric and biochemical variables of children and adolescents admitted to a Predialysis Interdisciplinary Management Program (PDIMP) responsible for the follow-up of children and adolescents at stages 2 to 4 of chronic kidney disease (CKD) at a tertiary center. One hundred thirty-eight patients with CKD on predialysis treatment with median age at admission of 9 years and the median follow-up time of 5 years were evaluated. …”
    Get full text
    Article
  6. 806

    Identification of Potential Serum Metabolic Biomarkers of Diabetic Kidney Disease: A Widely Targeted Metabolomics Study by Hang Zhang, Jing-jing Zuo, Si-si Dong, Yuan Lan, Chen-wei Wu, Guang-yun Mao, Chao Zheng

    Published 2020-01-01
    “…Background and Objectives. Diabetic kidney disease is a leading cause of chronic kidney disease and end-stage renal disease across the world. …”
    Get full text
    Article
  7. 807
  8. 808

    Urinary Uromodulin Levels and UMOD Variants in Black South Africans with Hypertension-Attributed Chronic Kidney Disease by Nolubabalo Unati Nqebelele, Caroline Dickens, Therese Dix-Peek, Raquel Duarte, Saraladevi Naicker

    Published 2019-01-01
    “…Patients with chronic kidney disease (CKD) have reduced urinary uromodulin levels secondary to tubular damage. …”
    Get full text
    Article
  9. 809
  10. 810
  11. 811
  12. 812

    Osseous Metaplasia in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney: A Case of Massive, Bilateral Tumors by Aeen M. Asghar, Matthew A. Uhlman, Laila Dahmoush, Sundeep Deorah

    Published 2015-01-01
    “…Renal cell carcinoma (RCC) is the most common kidney malignancy, with many histologic subtypes. …”
    Get full text
    Article
  13. 813

    Traumatic Page Kidney Induced Hypertension in Critical Care: Immediately Resolved or Long-Term Resistant Problem by E. Brotfain, L. Koyfman, A. Frenkel, A. Smolikov, A. Zlotnik, M. Klein

    Published 2013-01-01
    “…Page kidney is a well-known phenomenon causing hypertension, due to compression of renal parenchyma by a subcapsular hematoma, of either traumatic or non-traumatic origin. …”
    Get full text
    Article
  14. 814

    Classification and Regression Trees analysis identifies patients at high risk for kidney function decline following hospitalization. by Weihao Wang, Wei Zhu, Janos Hajagos, Laura Fochtmann, Farrukh M Koraishy

    Published 2025-01-01
    “…Clinicians should consider the length of hospitalization in post-discharge monitoring of kidney function.…”
    Get full text
    Article
  15. 815

    Composite Oncocytoma and Papillary Renal Cell Carcinoma of the Kidney Treated by Partial Nephrectomy: A Case Report by Michael S. Floyd, Saqib Javed, Keloth E. Pradeep, Alan R. De Bolla

    Published 2011-01-01
    “…Computerised tomography of her abdomen revealed a 38-mm mass in the lower pole of her left kidney. She underwent a partial nephrectomy, with final histopathological analysis confirming the presence of a concomitant oncocytoma and papillary cell carcinoma. …”
    Get full text
    Article
  16. 816

    Protective Effects of Carvacrol against Oxidative Stress Induced by Chronic Stress in Rat’s Brain, Liver, and Kidney by Saeed Samarghandian, Tahereh Farkhondeh, Fariborz Samini, Abasalt Borji

    Published 2016-01-01
    “…The present study was designed to investigate the protective effects of CAR on restraint stress induced oxidative stress damage in the brain, liver, and kidney. For chronic restraint stress, rats were kept in the restrainers for 6 h every day, for 21 consecutive days. …”
    Get full text
    Article
  17. 817

    Marfan Syndrome and Autosomal Dominant Polycystic Kidney Disease: A Case of Rare Co-occurrence or Coincidence? by Arjun Sekar

    Published 2022-09-01
    “… Background: Marfan syndrome (MFS) and autosomal dominant kidney disease (ADPKD) are two separate genetic disorders. …”
    Get full text
    Article
  18. 818

    High-intensity statin therapy in patients with chronic kidney disease: a systematic review and meta-analysis by Jing Wang, Ling Wu, Yu-Ling Yan, Bo Qiu, Song-Bai Deng, Xiao-Dong Jing, Jian-Lin Du, Ya-Jie Liu, Qiang She

    Published 2015-05-01
    “…Objective To evaluate the efficacy and safety of high-intensity statin therapy in patients with chronic kidney disease (CKD).Design A systematic review and meta-analysis.Data sources Randomised controlled trials (RCTs) comparing high-intensity statin therapy (atorvastatin 80 mg or rosuvastatin 20/40 mg) with moderate/mild statin treatment or placebo were derived from the databases (PubMed, Embase, Ovid, the Cochrane Central Register of Controlled Trials (CENTRAL) in the Cochrane Library, and ISI Web of Knowledge).Outcome measure Primary end points: clinical events (all-cause mortality, stroke, myocardial infarction and heart failure); secondary end points: serum lipid, renal function changes and adverse events.Results A total of six RCTs with 10 993 adult patients with CKD were included. …”
    Get full text
    Article
  19. 819

    Effectivity of Percutaneous Nephrolithotomy versus Retrograde Intrarenal Surgery on Kidney Stone: A Single-center Experience by Muhammad Fachri Fauzi, Tarmono Djojodimedjo, Mohammad Ayodhia Soebadi, Mohamad Fairuz Mohamad Sharin

    Published 2024-12-01
    “…Conclusions: Patients who underwent PCNL procedures for kidney stones are generally men over 40 years old with kidney stones larger than 2 cm and < 2 cm for RIRS procedures. …”
    Get full text
    Article
  20. 820

    Presence of an Isolated Hydatid Cyst in the Left Kidney: Report of a Case of This Rare Condition Managed Surgically by Daniel Paramythiotis, Petros Bangeas, Konstantinia Kofina, Vassileios Papadopoulos, Antonios Michalopoulos

    Published 2016-01-01
    “…Hydatid cyst disease caused by Echinococcus granulosus is rarely presented in the kidneys, whereas isolated renal occurrence is estimated to be about as low as 2–4% of all cases. …”
    Get full text
    Article